MindMaze Therapeutics Announces Results of Annual General Meeting

AI SummaryClose X

MindMaze Therapeutics Holding SA announced the results of its Annual General Meeting where shareholders approved all proposals except for the proposed increase in conditional share capital. Key approvals included the re-election of Walid Hanna, Olaf Blanke, and Martin Reiss to the Board of Directors, alongside the election of Brad Hollinger and Zach Henderson as new board members. Shareholders also ratified the 2025 Annual Report and financial statements, appropriation of earnings, discharge of board and executive committee members, and compensation proposals.

Disclaimer*

UK 100

Latest directors dealings